Valuation Ind-Swift Laboratories Limited

Stocks

Delayed NSE India S.E. 04:35:08 09/11/2026 pm IST			5-day change	1st Jan Change
349.05 ^INR	+0.24%		-1.19%	+295.97%

29/10	Ind-Swift Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026	CI
06/10	Ind-Swift Laboratories Limited Approves Appointment of Amit Mathur as Independent Director	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	4,251	3,938	3,262	5,918	4,961	11,397
Change	-	-7.37%	-17.18%	81.43%	-16.17%	129.72%
Enterprise Value (EV) ¹	14,189	13,254	11,701	1,764	695.5	7,184
Change	-	-6.59%	-11.72%	-84.92%	-60.59%	932.99%
P/E	-135x	-183x	6.85x	1.41x	2.38x	26.1x
PBR	0.7x	0.66x	0.48x	0.64x	0.49x	0.82x
PEG	-	5.8x	-0x	0x	-0x	-0.3x
Capitalization / Revenue	0.47x	0.37x	0.27x	0.46x	0.88x	1.76x
EV / Revenue	1.56x	1.26x	0.96x	0.14x	0.12x	1.11x
EV / EBITDA	8.54x	5.96x	4.9x	0.66x	-3.19x	16.1x
EV / EBIT	12.8x	14.3x	6.45x	0.82x	-1.59x	43.9x
EV / FCF	58x	49.3x	26.6x	0.18x	-0.33x	-5.29x
FCF Yield	1.72%	2.03%	3.76%	558%	-302%	-18.9%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.5326	-0.3637	8.055	71.24	35.21	5.03
Distribution rate	-	-	-	-	-	-
Net sales ¹	9,068	10,521	12,159	12,973	5,617	6,491
EBITDA ¹	1,661	2,224	2,389	2,683	-217.8	445.2
EBIT ¹	1,110	924.1	1,815	2,150	-438.6	163.7
Net income ¹	-31.47	-21.49	476	4,210	2,505	431.2
Net Debt ¹	9,938	9,315	8,439	-4,153	-4,265	-4,212
Reference price ²	71.95	66.65	55.20	100.15	83.96	131.43
Nbr of stocks (in thousands)	59,087	59,087	59,087	59,087	59,087	86,712
Announcement Date	07/09/21	07/09/22	05/09/23	06/09/24	05/09/25	05/09/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
IND-SWIFT LABORATORIES LIMITED	-	-	-	-	31Cr
ELI LILLY AND COMPANY	39.62x	13.42x	28.51x	0.5%	1,20600Cr
JOHNSON & JOHNSON	40.43x	6.79x	19.09x	1.93%	66TCr
ABBVIE INC.	37.52x	8.51x	17.57x	2.38%	51TCr
ROCHE HOLDING AG	20.98x	5.12x	12.74x	2.57%	38TCr
MERCK & CO., INC.	104.15x	5.94x	25.33x	2.32%	36TCr
NOVARTIS AG	23.47x	5.94x	14.26x	2.69%	31TCr
ASTRAZENECA PLC	24.46x	4.89x	13.77x	1.79%	29TCr
AMGEN INC.	23.75x	7.3x	13.55x	2.19%	25TCr
GILEAD SCIENCES, INC.	-39.18x	7.27x	45.77x	1.98%	21TCr
Average	30.58x	7.24x	21.18x	2.04%	41.8TCr
Weighted average by Cap.	36.30x	8.55x	21.85x	1.73%